News
Pfizer Inc. (NYSE:PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...
Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...
Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.
Cogent Biosciences, Inc. is a Strong Buy after trial data for bezuclastinib & market growth potential in systemic ...
The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo ...
6d
24/7 Wall St. on MSNWill The Tariff "Taco Trade" End The Rally? 5 High-Yield Value Stocks Are Strong Buys NowThis post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
In a market where mega-cap growth and tech stocks continue to dominate headlines and stretch valuations, income-oriented investors may feel sidelined. But for those with a long-term perspective ...
Donald Trump launched new tariffs on Wednesday, which included raising duty on Brazilian imports to 50pc from 10pc, effective ...
Pfizer Share Price – Track LIVE BSE/NSE stock prices of Pfizer with insights on performance, fundamentals, market cap, shareholding, financials, company profile, balance sheet, annual and quarterly ...
In 2022, over 1 billion people were affected by obesity, driving innovation in therapeutic advancements. Emerging treatments focus on appetite contro ...
Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results